Fundamentals: Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment. Average 1 year target from analysts = 54.
Technical: To allow the stock some fluctuation the stop could be around 40.2 level. Target could be around the previous...
Classics of the genre. A young and beautiful company that has everything ready to make friends with you, that is, the Triangle pattern, which has already been formed and broken up. Now the price will move along the indicated arrows and reach the main target of the trade of 72.44 dollars (an increase of 54%). It makes no sense to put a stop here.
